Decoy Therapeutics is trading 12.72% up at $3.19 in pre-market, with no fresh company-specific catalyst identified.
- Latest notable news was September 15 shareholder approval of warrant issuance and reduced authorized shares.
- Broader futures were mixed and below the threshold for a clear market-wide explanation.